Kevin D. Bunker, Chief Scientific Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 14,114 shares at $20.42 ($285K) on 2023-02-13, disclosed to the SEC on 2023-02-14.
Open-market sale of $285k ZNTL by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.42 | 3,807 | $78K | 27.2% |
| 2 | $20.42 | 3,807 | $78K | 27.2% |
| 3 | $19.98 | 6,500 | $130K | 45.5% |
| Total | $20.22 avg | 14,114 | $285K | 100% |
| Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-14 | $300K | — | Filing → |